Bryn Pharma Completes Dosing in Pivotal Clinical Trial Designed to Support US Approval of Intranasal Epinephrine Spray - PRNewswire

Bryn Pharma Completes Dosing in Pivotal Clinical Trial Designed to Support US Approval of Intranasal Epinephrine Spray  PRNewswire